Direct Flow Medical gets $27.1mm in financing

Direct Flow Medical Inc. (developing transcatheter heart valves) raised $27.1mm in a late-stage financing to 11 investors. According the Form D, the company sold and issued Series A-1 preferred stock, Series AA preferred stock, convertible notes, warrants to purchase Series A-1 or preferred stock, Series A-1 or preferred stock upon exercise, and the underlying common stock issuable upon conversion. Direct Flow Medical's last fund-raise was in late-2014 through the sale of $17mm in Series C-1 preferred shares.